Thu, May 9, 2024
Wed, May 8, 2024
Tue, May 7, 2024

Rachel Vatnsdal Maintained (ADPT) at Buy with Decreased Target to $5 on, May 8th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-5-on-may-8th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Rachel Vatnsdal of JP Morgan, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Buy with Decreased Target from $8 to $5 on, May 8th, 2024.

Rachel has made no other calls on ADPT in the last 4 months.



There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Rachel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $5 on, Friday, February 16th, 2024


This is the rating of the analyst that currently disagrees with Rachel


  • Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $5 on, Thursday, April 4th, 2024

Publication Contributing Sources